62 related articles for article (PubMed ID: 6366037)
1. [Promegestone, a new progestin].
Raynaud JP; Ojasoo T
J Gynecol Obstet Biol Reprod (Paris); 1983; 12(7):697-710. PubMed ID: 6366037
[TBL] [Abstract][Full Text] [Related]
2. [Clinical use of promegestone, a progestational agent with high specificity for receptors].
Brun G; Dargent D; Pontonnier G; Petrescou L
Rev Fr Gynecol Obstet; 1984 May; 79(5):423-6. PubMed ID: 6396815
[No Abstract] [Full Text] [Related]
3. The pharmacological profile of a novel norpregnance progestin (trimegestone).
Philibert D; Bouchoux F; Degryse M; Lecaque D; Petit F; Gaillard M
Gynecol Endocrinol; 1999 Oct; 13(5):316-26. PubMed ID: 10599548
[TBL] [Abstract][Full Text] [Related]
4. Progestin effects on growth in the human breast cancer cell line T-47D--possible therapeutic implications.
Hissom JR; Moore MR
Biochem Biophys Res Commun; 1987 Jun; 145(2):706-11. PubMed ID: 3593365
[TBL] [Abstract][Full Text] [Related]
5. Comparative effects of chlormadinone acetate and its 3alpha- and 3beta-hydroxy metabolites on progesterone, androgen and glucocorticoid receptors.
Schneider J; Kneip C; Jahnel U
Pharmacology; 2009; 84(2):74-81. PubMed ID: 19590256
[TBL] [Abstract][Full Text] [Related]
6. Steroid hormone receptors as targets for the therapy of breast and prostate cancer--recent advances, mechanisms of resistance, and new approaches.
Hoffmann J; Sommer A
J Steroid Biochem Mol Biol; 2005 Feb; 93(2-5):191-200. PubMed ID: 15860262
[TBL] [Abstract][Full Text] [Related]
7. New progestagens for contraceptive use.
Sitruk-Ware R
Hum Reprod Update; 2006; 12(2):169-78. PubMed ID: 16291771
[TBL] [Abstract][Full Text] [Related]
8. Selectivity and potency of the retroprogesterone dydrogesterone in vitro.
Rižner TL; Brožič P; Doucette C; Turek-Etienne T; Müller-Vieira U; Sonneveld E; van der Burg B; Böcker C; Husen B
Steroids; 2011 May; 76(6):607-15. PubMed ID: 21376746
[TBL] [Abstract][Full Text] [Related]
9. Effects of progesterone, promegestone and RU 486 on glucocorticoid receptor levels in primary cultures of mouse mammary epithelial cells.
Schneider W; Gauthier Y; Shyamala G
J Steroid Biochem; 1988 Jun; 29(6):599-604. PubMed ID: 3386227
[TBL] [Abstract][Full Text] [Related]
10. Radiosequence analysis of the human progestin receptor charged with [3H]promegestone. A comparison with the glucocorticoid receptor.
Strömstedt PE; Berkenstam A; Jörnvall H; Gustafsson JA; Carlstedt-Duke J
J Biol Chem; 1990 Aug; 265(22):12973-7. PubMed ID: 2376583
[TBL] [Abstract][Full Text] [Related]
11. Biochemical basis of breast cancer treatment by androgens and progestins.
Rochefort H
Prog Clin Biol Res; 1984; 142():79-95. PubMed ID: 6538685
[No Abstract] [Full Text] [Related]
12. The effect of progestins on estrogen and progesterone receptors in the human endometrium.
Natrajan PK; Muldoon TG; Greenblatt RB; Mahesh VB
J Reprod Med; 1982 Apr; 27(4):227-30. PubMed ID: 7201523
[No Abstract] [Full Text] [Related]
13. [Observations on the new progestational agents].
Drapier-Faure E; Payan F
Rev Fr Gynecol Obstet; 1987 Dec; 82(12):733-8. PubMed ID: 3432896
[TBL] [Abstract][Full Text] [Related]
14. Bromocriptine and norethisterone in the treatment of premenstrual syndrome.
Ylöstalo P; Kauppila A; Puolakka J; Rönnberg L; Jänne O
Obstet Gynecol; 1982 Mar; 59(3):292-8. PubMed ID: 6804900
[TBL] [Abstract][Full Text] [Related]
15. The estrogenic activity of synthetic progestins used in oral contraceptives enhances fatty acid synthase-dependent breast cancer cell proliferation and survival.
Menendez JA; Oza BP; Colomer R; Lupu R
Int J Oncol; 2005 Jun; 26(6):1507-15. PubMed ID: 15870863
[TBL] [Abstract][Full Text] [Related]
16. Biological activity and receptor binding of a strongly interacting estrogen in human breast cancer cells.
Reiner GC; Katzenellenbogen BS; Bindal RD; Katzenellenbogen JA
Cancer Res; 1984 Jun; 44(6):2302-8. PubMed ID: 6547074
[TBL] [Abstract][Full Text] [Related]
17. Progestins and breast cancer.
Pasqualini JR
Gynecol Endocrinol; 2007 Oct; 23 Suppl 1():32-41. PubMed ID: 17943537
[TBL] [Abstract][Full Text] [Related]
18. Progesterone crosstalks with insulin-like growth factor signaling in breast cancer cells via induction of insulin receptor substrate-2.
Cui X; Lazard Z; Zhang P; Hopp TA; Lee AV
Oncogene; 2003 Oct; 22(44):6937-41. PubMed ID: 14534541
[TBL] [Abstract][Full Text] [Related]
19. Preclinical and clinical properties of trimegestone: a potent and selective progestin.
Sitruk-Ware R; Bossemeyer R; Bouchard P
Gynecol Endocrinol; 2007 Jun; 23(6):310-9. PubMed ID: 17616854
[TBL] [Abstract][Full Text] [Related]
20. Steroid receptors in human renal carcinoma.
Chen L; Weiss FR; Chaichik S; Keydar I
Isr J Med Sci; 1980 Nov; 16(11):756-60. PubMed ID: 7192273
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
